BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11898580)

  • 1. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
    Kaplan ED; Sacco RL
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke subtypes and interventional studies for transient ischemic attack.
    Lavallée P; Amarenco P
    Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary stroke prevention: review of clinical trials.
    Elkind MS
    Clin Cardiol; 2004 May; 27(5 Suppl 2):II25-35. PubMed ID: 15188933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
    Kirshner HS
    Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient ischemic attack: risk stratification and treatment.
    Cucchiara B; Ross M
    Ann Emerg Med; 2008 Aug; 52(2):S27-39. PubMed ID: 18655916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern strategies for the management of patients who have suffered ischemic stroke or transient ischemic attack].
    Shirokov EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(12. Vyp. 2):61-67. PubMed ID: 38148699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.
    Furie KL; Kasner SE; Adams RJ; Albers GW; Bush RL; Fagan SC; Halperin JL; Johnston SC; Katzan I; Kernan WN; Mitchell PH; Ovbiagele B; Palesch YY; Sacco RL; Schwamm LH; Wassertheil-Smoller S; Turan TN; Wentworth D;
    Stroke; 2011 Jan; 42(1):227-76. PubMed ID: 20966421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.
    Kapil N; Datta YH; Alakbarova N; Bershad E; Selim M; Liebeskind DS; Bachour O; Rao GHR; Divani AA
    Clin Appl Thromb Hemost; 2017 May; 23(4):301-318. PubMed ID: 27461564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale.
    Ovbiagele B
    J Emerg Med; 2008 May; 34(4):389-96. PubMed ID: 18207691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulants and non-cardioembolic stroke prevention.
    Schachter ME; Tran HA; Anand SS
    Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on selecting and adjusting antiplatelet therapy for prevention of noncardiogenic, recurrent ischemic stroke.
    Lutsep H
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1295-303. PubMed ID: 21985542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke: JACC State-of-the-Art Review.
    Greco A; Occhipinti G; Giacoppo D; Agnello F; Laudani C; Spagnolo M; Mauro MS; Rochira C; Finocchiaro S; Mazzone PM; Faro DC; Landolina D; Ammirabile N; Imbesi A; Raffo C; Capodanno D
    J Am Coll Cardiol; 2023 Oct; 82(15):1538-1557. PubMed ID: 37793752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.